Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Molecular Oncology
|
August 17, 2018
From validity to clinical utility: the influence of circulating tumor DNA on melanoma patient management in a real-world setting
Steven P Rowe, Brandon Luber, Monique Makell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 7, 2017
Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration-Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide
Emmanuel S Antonarakis, Changxue Lu, Brandon Luber, et al.
Journal of Translational Medicine
|
July 6, 2015
Safety and immunologic correlates of Melanoma GVAX, a GM-CSF secreting allogeneic melanoma cell vaccine administered in the adjuvant setting
Evan J Lipson, William H Sharfman, Shuming Chen, et al.
Annals of Surgical Oncology
|
July 31, 2015
Evaluation of Adjuvant Radiation Therapy for Resected Gallbladder Carcinoma: A Multi-institutional Experience
Jingya Wang, Amol K Narang, Elizabeth A Sugar, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 16, 2017
Reduced-Intensity Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Solid Tumors in Pediatric and Young Adult Patients
Nicolas J Llosa, Kenneth R Cooke, Allen R Chen, et al.
Cancer Immunology Research
|
August 24, 2019
Immunopathologic Stratification of Colorectal Cancer for Checkpoint Blockade Immunotherapy
Nicolas J Llosa, Brandon Luber, Nicholas Siegel, et al.
The Lancet. Oncology
|
December 18, 2017
Bipolar androgen therapy in men with metastatic castration-resistant prostate cancer after progression on enzalutamide: an open-label, phase 2, multicohort study
Benjamin A Teply, Hao Wang, Brandon Luber, et al.
The New England Journal of Medicine
|
September 4, 2014
AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer
Emmanuel S Antonarakis, Changxue Lu, Hao Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 8, 2019
Intratumoral Adaptive Immunosuppression and Type 17 Immunity in Mismatch Repair Proficient Colorectal Tumors
Nicolas J Llosa, Brandon Luber, Ada J Tam, et al.
Oncotarget
|
July 10, 2018
Ipilimumab plus nivolumab and DNA-repair defects in AR-V7-expressing metastatic prostate cancer
Karim Boudadi, Daniel L Suzman, Valsamo Anagnostou, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Molecular Oncology
|
August 17, 2018
From validity to clinical utility: the influence of circulating tumor DNA on melanoma patient management in a real-world setting
Steven P Rowe, Brandon Luber, Monique Makell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 7, 2017
Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration-Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide
Emmanuel S Antonarakis, Changxue Lu, Brandon Luber, et al.
Journal of Translational Medicine
|
July 6, 2015
Safety and immunologic correlates of Melanoma GVAX, a GM-CSF secreting allogeneic melanoma cell vaccine administered in the adjuvant setting
Evan J Lipson, William H Sharfman, Shuming Chen, et al.
Annals of Surgical Oncology
|
July 31, 2015
Evaluation of Adjuvant Radiation Therapy for Resected Gallbladder Carcinoma: A Multi-institutional Experience
Jingya Wang, Amol K Narang, Elizabeth A Sugar, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 16, 2017
Reduced-Intensity Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Solid Tumors in Pediatric and Young Adult Patients
Nicolas J Llosa, Kenneth R Cooke, Allen R Chen, et al.
Cancer Immunology Research
|
August 24, 2019
Immunopathologic Stratification of Colorectal Cancer for Checkpoint Blockade Immunotherapy
Nicolas J Llosa, Brandon Luber, Nicholas Siegel, et al.
The Lancet. Oncology
|
December 18, 2017
Bipolar androgen therapy in men with metastatic castration-resistant prostate cancer after progression on enzalutamide: an open-label, phase 2, multicohort study
Benjamin A Teply, Hao Wang, Brandon Luber, et al.
The New England Journal of Medicine
|
September 4, 2014
AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer
Emmanuel S Antonarakis, Changxue Lu, Hao Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 8, 2019
Intratumoral Adaptive Immunosuppression and Type 17 Immunity in Mismatch Repair Proficient Colorectal Tumors
Nicolas J Llosa, Brandon Luber, Ada J Tam, et al.
Oncotarget
|
July 10, 2018
Ipilimumab plus nivolumab and DNA-repair defects in AR-V7-expressing metastatic prostate cancer
Karim Boudadi, Daniel L Suzman, Valsamo Anagnostou, et al.
Page
of 3